Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II – Piperazines/Piperidines, Phenylethylamines, Tryptamines and miscellaneous ‘Others’

Przemysław Biliński 1, Piotr Hołownia 2, Lucyna Kapka-Skrzypczak 3, Andrzej Wojtyła 4
1 - Chief Sanitary Inspectorate, Warsaw, Poland; Institute of Haematology and Transfusion Medicine, Warsaw, Poland
2 - Chief Sanitary Inspectorate, Warsaw, Poland
3 - Independent Laboratory of Molecular Biology, Institute of Rural Health, Lublin, Poland; Department of Public Health, University of Information Technology and Management, Rzeszow, Poland
4 - Department of Mother and Child Health, University of Medical Sciences, Poznan, Poland; Department of Higiene, Chair of Social Medicine, University of Medical Sciences, Poznan, Poland
Ann Agric Environ Med
2012; 19 (4):
ICID: 1024091
Article type: Other
As the second and concluding part, this paper continues the summary review of the scientific evidence obtained from the literature and focuses on the remaining 4/6 groupings of DDs identified in illegal products found in the huge drug seizures made recently in Poland. They consist of piperazines/piperidines, phenylethylamines, tryptamines, (briefly mentioned), and a miscellaneous ‘others’ category; cannabinoids and cathinones derivatives having being reviewed in the first part. Also included in the introduction and discussion sections, in both reviews, are some legal aspects variously interwoven with the science. It is thus intended that these two articles may help suitable legislation to be rapidly devised to make the prohibition of DDs permanent whenever deemed necessary, as well as providing an up-to-date reference source for those engaged in the DD issue; whether scientists or regulatory bodies.
PMID 23311821 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     New Psychoactive Substances [4 related records]
     Legal highs [14 related records]
     Designer Drugs [9 related records]


Related articles

D Wiszejko-Wierzbicka, M Kidawa,
Motywy zażywania i typologia użytkowników nowyc...
Wprowadzenie Scena nowych substancji psychoaktywnych (NSP) przyciąga ludzi z różnymi potrzebami, kierujących się różnymi motywami. NSP, tzw. designer drugs, dla wielu z nich wydają się być odpowiedzią na to, co przynosi współczesna rzec...
A Wiesner, A Tyl,
Methoxetamine – a novel psychoactive substance (...
During the last decade, numerous new psychoactive substances have appeared on the illegal recreational drug market. One of them is methoxetamine, a structural analogue of ketamine. The increasing popularity of methoxetamine as a recreational drug may...
K Krajewski,
Risk assessment of new psychoactive substance use ...
Standard approach to defining notions of narcotic drugs and psychotropic substances is scheduling them in appendices to drug laws. This method is precise, although not very flexible. It also raises questions regarding scientific evidence used to put ...